Literature DB >> 8809087

Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus.

E P Neve1, E Eliasson, M A Pronzato, E Albano, U Marinari, M Ingelman-Sundberg.   

Abstract

It has been reported that cytochrome P450 is expressed in the plasma membrane of hepatocytes isolated from human and rat. Cytochrome P450s expressed on the cell surface are potential targets for the immune response of drug-induced and autoimmune hepatitis. However, the mechanisms behind transport of cytochrome P450 to the plasma membrane are obscure. The present investigation aimed at identifying cytochrome P450 expressed in the Golgi apparatus. Golgi membrane fractions from rat liver were prepared and characterized: one enriched with cis-Golgi, one highly enriched with trans-Golgi, and one intermediate Golgi fraction representing medial-Golgi. In these three fractions, significant amounts of cytochrome P450 and NADPH cytochrome P450 reductase were present, which could not be accounted for by contamination with endoplasmic reticulum. A marked difference between the relative content of different cytochrome P450 enzymes was found. CYP4A1 was found at the highest concentration, CYP2E1 at an intermediary level, and CYP1A2 at low levels, whereas no Golgi-specific CYP3A1 was detectable. It was also shown that the CYP2E1 present in the Golgi fractions was catalytically active. It is suggested that various forms of hepatic cytochrome P450 are transported to the plasma membrane through the Golgi apparatus in an enzyme-specific manner.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809087     DOI: 10.1006/abbi.1996.0415

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

Review 1.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

2.  Metabolization of porphyrinogenic agents in brain: involvement of the phase I drug metabolizing system. A comparative study in liver and kidney.

Authors:  Jimena V Lavandera; Alcira Maria Del Carmen Batlle; Ana María Buzaleh
Journal:  Cell Mol Neurobiol       Date:  2007-08-04       Impact factor: 5.046

3.  Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress.

Authors:  Seema Bansal; Chuan-Peng Liu; Naresh B V Sepuri; Hindupur K Anandatheerthavarada; Venkatesh Selvaraj; Jan Hoek; Ginger L Milne; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

4.  Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.

Authors:  A Zhukov; M Ingelman-Sundberg
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

5.  Methionine Adenosyltransferase α1 Is Targeted to the Mitochondrial Matrix and Interacts with Cytochrome P450 2E1 to Lower Its Expression.

Authors:  Ben Murray; Hui Peng; Lucia Barbier-Torres; Aaron E Robinson; Tony W H Li; Wei Fan; Maria Lauda Tomasi; Roberta A Gottlieb; Jenny Van Eyk; Zhimin Lu; Maria L Martínez-Chantar; Suthat Liangpunsakul; Nicholas J Skill; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2019-06-25       Impact factor: 17.425

6.  Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

Authors:  L Muratori; M Parola; A Ripalti; G Robino; P Muratori; G Bellomo; R Carini; M Lenzi; M P Landini; E Albano; F B Bianchi
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 7.  CYP2E1 and oxidative liver injury by alcohol.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2007-11-17       Impact factor: 7.376

8.  Proteasome inhibition compromises direct retention of cytochrome P450 2C2 in the endoplasmic reticulum.

Authors:  Elzbieta Szczesna-Skorupa; Byron Kemper
Journal:  Exp Cell Res       Date:  2008-08-15       Impact factor: 3.905

Review 9.  Pathophysiological implications of neurovascular P450 in brain disorders.

Authors:  Chaitali Ghosh; Mohammed Hossain; Jesal Solanki; Aaron Dadas; Nicola Marchi; Damir Janigro
Journal:  Drug Discov Today       Date:  2016-06-14       Impact factor: 7.851

10.  Acetaldehyde and parkinsonism: role of CYP450 2E1.

Authors:  Francesca Vaglini; Cristina Viaggi; Valentina Piro; Carla Pardini; Claudio Gerace; Marco Scarselli; Giovanni Umberto Corsini
Journal:  Front Behav Neurosci       Date:  2013-06-21       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.